Second malignancies in patients with hairy cell leukemia in British Columbia: A 20-year experience

Blood

Volumn 92, Issue 4, 1998, Pages 1160-1164

  Au, Wing Y ^a   Klasa, Richard J ^a   Gallagher, Richard ^a   Le, Nhu ^a   Randy, D ^a   Gascoyne, ^a   Connors, Joseph M ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALPHA INTERFERON; CLADRIBINE; PENTOSTATIN; PURINE DERIVATIVE;

ADULT; AGE; AGED; ARTICLE; CANADA; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL CARCINOMA; HAIRY CELL LEUKEMIA; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SECOND CANCER; SKIN CANCER; SPLENECTOMY; TUMOR RECURRENCE;

EID: 0032529702     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1160     Document Type: Article

References (39)

1. Bouroncle BA, Wiseman BK, Doan CA: Leukemic reticuloendotheliosis. Blood 13:609, 1958
2. Jansen J, Hermans J: Splenectomy in hairy cell leukemia: A retrospective multicenter analysis. Cancer 47:2066, 1981
3. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU: Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 310:15, 1984
4. Kraut EH, Grever MR, Bouroncle: Long term follow up of patients with hairy cell leukemia after treatment with 2 deoxycoformycin. Blood 84:4061, 1994
5. Piro LD, Carrera CJ, Carson DA, Beutier E: Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 322:1117, 1990
6. Saven A, Piro LD: Treatment of hairy cell leukemia. Blood 79:1111, 1992
7. Jacobs RH, Yokes EE, Colomb HM: Second malignancies in hairy cell leukemia. Cancer 56:1462, 1985
8. Kwong YL, Liang R, Chiu E, Chan DW, Chan TK: Hairy cell leukemia: Treatment results and association with secondary malignancy. Am J Hematol 26:291, 1992 (letter)
9. Lopera GA, Alvarez OA, Lee M: Large cell lymphoma of the colon presenting as a second malignancy in a patient with hairy cell leukemia. J Clin Gastroenterol 21:259, 1995
10. Diaz-Pavon JR, Pugh W, Cabanillas F: Simultaneous presentation of hairy cell leukemia and follicular small cleaved cell lymphoma in patient with previous diagnosis of renal cell carcinoma. Hematol Oncol 13:63, 1995
11. Stewart DF, Keating MJ: Second malignancies in hairy cell leukemia (leukemic reticuloendotheliosis). Am J Hematol 13:167, 1982
12. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman JM: Increased incidence of second neoplasms in patients treated with interferon alpha for hairy cell leukemia: A clinicopathologic assessment. Blood 83:2931, 1994
13. Kurzrock R, Strom SS, Estey E, O'Brien S, Keating MJ, Jiang H, Adams T, Talpaz M: Second cancer risk in hairy cell leukemia: Analysis of 350 patients. J Clin Oncol 15:1803, 1997
14. Cancer in Canada 1975-1991: National Cancer Institute of Canada: Canadian cancer statistics
15. Breslow NE, Day NE: Statistical methods in cancer research, vol 2. The design and analysis of cohort studies. International Agency for Research on Cancer, Lyon, France, 1987 (IARC scientific publication no. 82)
16. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Med Assoc 53:457, 1958
17. Connors JM, Silver HK: Phase I study of weekly high dose human lymphoblastoid interferon. Cancer Treat Rep 69:1096, 1985
18. Smalley RV, Anderson SA, Tuttle RL , Connors JM, Thurmond LM, Huang A, Castle K, Magers C, Whisnant JK: A randomized comparison of two doses of human lymphoblastoid interferon alpha in hairy cell leukemia. Blood 78:3133, 1991
19. Smalley RV, Connors JM, Tuttle RL, Anderson S, Robinson W, Whisnant A: Splenectomy versus alpha interferon: A randomized study in patients with previously untreated hairy cell leukemia. Am J Hematol 41:13, 1992
20. Grever M, Kopecky K, Foucar K, Head D, Bennett JM, Hutchison RE, Corbel WEN, Cassileth PA, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson BD: Randomized comparison of pentostatin versus interferon alfa 2a in previously untreated patients with hairy cell leukemia: An intergroup study. J Clin Oncol 13:974, 1995
21. Mintz U, Golomb HM: Splenectomy as initial therapy in twenty six patients with leukemic reticuloendothelisosis (hairy cell leukemia). Cancer Res 39:2366, 1979
22. Golomb HM, Ratain MJ, Mick R, Daly K: Interferon treatment for hairy cell leukemia: An update on a cohort of 69 patients treated from 1983-1986. Leukemia 6:1177, 1992
23. Berman E, Heller G, Kempin S, Gee T, Tran LL, Clarkson B: Incidence of response and long term follow up in patients with hairy cell leukemia treated with recombinant interferon alfa 2a Blood 75:839, 1990
24. Bernstein L, Newton P, Ross RK: Epidemiology of hairy cell leukemia in Los Angeles county. Cancer Res 50:3605, 1990
25. Frassoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco G, Dini E, Resegotti L, Damasio EE, Silingardi V: Hairy cell leukemia: A clinical review based on 725 cases of the Italian Cooperative Group. Leuk Lymphoma 13:307, 1994
26. Smith JW, Longo DL, Urba W, Clark JW, Watson T, Beveridge J, Conlon KC, Sznol M, Creekmore SP, Alvord WF, Lawrence JB, Steis RG: Prolonged, continuous treatment of hairy cell leukemia patients with recumbent interferon a2a. Blood 78:1664, 1991
27. Lauria F, Rondelli D, Zinzani PL, Bocchia M, Maotta G, Salvucci M, Raspadori D, Ventura MA, Birtolo S, Forconi F, Tura S: Long lasting complete remission in patients with hairy cell leukemia treated with 2CDA: A 5 year survey. Leukemia 11:629, 1997
28. Troussard X, Henry-Amar M, Flandrin G: Secondary cancer risk after interferon therapy? Blood 84:3242, 1994 (letter)
29. Pawson R, A'hern R, Catovsky D: Second malignancy in hairy cell leukemia: No evidence of increased incidence after treatment with interferon alpha. Leuk Lymphoma 22:103, 1996
30. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr: Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 84:1422, 1992
31. Ruco LP, Procopio A, Maccallini V, Calogero A, Uccini S, Annino L, Mandelli F, Baroni CD: Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia. Blood 61:1132, 1983
32. Teichmann JV, Sieber G, Ludwig WD, Ruehl H: Immunosuppressive effects of recombinant interferon alpha during long term treatment of cancer patients. Cancer 63:1989, 1990
33. Seymour JF, Kurzrock R, Freireich EJ, Estey EH: 2 CDA induces durable remissions and prolonged suppression of CD4 lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906, 1994
34. Emilia G, Luppi M, Gandini G, Bertesi M, Torelli G: Hairy cell leukemia, second cancer and occupational risk. Br J Haematol 78:518, 1995
35. Downing JR, Grossi CE, Smedberg CT, Burrows PD: Diffuse large cell lymphoma in a patient with hairy cell leukemia: Immunoglobulin gene analysis reveals separate clonal origins. Blood 67:739, 1986
36. Arnalich F, Camacho J, Jimenez C, Lahoz C, Patron M: Occurrence of immunoblastic B cell lymphoma in hairy cell leukemia. Cancer 59:1161, 1987
37. Lawlor E, O'Brian S, Finn T, Ward R, Rogers FM, O'Brien AA, Daly PA: The simultaneous presentation of peripheral T cell lymphoma and hairy cell leukemia. Cancer 60:1537, 1987
38. Abbondanzo SL, Sulak LE: Ki-1 positive lymphoma developing 10 years after the diagnosis of hairy cell leukemia. Cancer 67:3117, 1991
39. Knecht H, Sarraj A, Delacretaz F, Bachmann E, Clement F: Genotypic and phenotypic evidence of T cell leukemia in a patient successfully treated by interferon alpha for typical hairy cell leukemia. Leukemia 5:1031, 1991